Volume : 11, Issue : 12, December – 2024
Title:
RP-HPLC TECHNIQUE FOR SIMULTANEOUS ESTIMATION OF REMOGLIFLOZIN AND METFORMIN IN BULK AND FORMULATION
Authors :
B.Gayathri , P.Aravindra Reddy
Abstract :
The most common and powerful approach for drug analysis is high-performance liquid chromatography. The current study focuses on the development and validation of innovative RP-HPLC analytical techniques for the development of drug contents in solid oral dosage forms. In the therapeutic drug monitoring and pharmaceutical sectors, method development is critical. It is always preferable to choose and develop a method for determining pharmaceuticals in pharmaceutical dosage forms and biological fluid samples that is straightforward, accurate, exact, and cost-effective. In the discovery, development, and production of drugs and pharmaceuticals, analytical method development and validation are critical. The new simple, novel, precise, rapid, reliable, accurate, and reproducible reverse-phase high-performance liquid chromatography (RP-HPLC) technique for simultaneous estimation of Remogliflozin and Metformin in bulk and formulation. The separation was achieved using ODS, C18 (250 mm × 4.6 mm, i.d.2.5 µm) column with isocratic elution. A mixture of acetonitrile: 20 mM ammonium formate buffer (pH 3.5) at the ratio of (60:40) as a mobile phase with a flow rate of 1.0 ml min-1 was used for the separation of analytes. The separated effluents were monitored with a diode array detector at 243 nm. The results showed good linearity over a range of 2.5–25 μg ml-1 and 12.5–125 μg ml-1 for Remogliflozin and Metformin respectively. Furthermore, the average percentage assay of marketed formulations of Remogliflozin and Metformin was found to be 100.30% and 100.52 %, respectively. Remogliflozin limit of detection (LOD) and limit of quantitation (LOQ) were 0.42 and 1.28 μg ml-1while LOD and LOQ for Metformin were 1.97 and 5.96 μg ml-1 respectively.
Keywords: Remogliflozin, Metformin, Simultaneous estimation, Method development, ICH, RP-HPLC.
Cite This Article:
Please cite this article in press P.Aravindra Reddy et al Rp-Hplc Technique For Simultaneous Estimation Of Remogliflozin And Metformin In Bulk And Formulation.,Indo Am. J. P. Sci, 2024; 11 (12).
Number of Downloads : 10
References:
1. Ganorkar SB, Shirkhedkar AA. Design of experiments in liquid chromatography (HPLC) analysis of pharmaceuticals: Analytics, applications, implications and future prospects. Reviews in Analytical Chemistry. 2017;36(3):1-43.
2. Awotwe-Otoo D, Agarabi C, Faustino PJ, Habib MJ, Lee S, Khan MA, Shah RB. Application of quality by design elements for the development and optimization of an analytical method for protamine sulfate. Journal of pharmaceutical and biomedical analysis. 2012;62:61-7.
3. Siregar C, Prabaningdyah NK, Choiri S, Riyanto S, Rohman A. Optimization of HPLC using central composite design for determination of curcumin and demethoxycurcumin in tablet dosage form. Dhaka University Journal of Pharmaceutical Sciences. 2017;16(2):137-45.
4. Lestari AD, Rohman A, Martono S. Central Composite Design Applied in HPLC Optimization For Analysis of Tartrazine And Auramine O in Powder Drinks. International Journal of Applied Pharmaceutics. 2019;7:211-5.
5. International Union of Pure and Applied Chemistry. Plate number (in chromatography), IUPAC Compendium of Chemical Terminology, Research Triangle Park, NC. 1997.
6. McNair HM and Bonelli EJ (1969) Basic gas chromatography, Varian, Palo Alto, CA.1969.
7. Lindholm J. Development and validation of HPLC methods for analytical and preparative purposes (Doctoral dissertation, Acta Universitatis Upsaliensis).2004.
8. Guideline IH. Stability testing of new drug substances and products. Q1A (R2), current step. 2003;4:1-24.
9. Brummer H, “How to Approach a Forced Degradation Study”, Life sci. tech bul., 2011.
10. Urvi S, Nilesh P, Ashok P, Amit V, “Stability Indicating RP-HPL Method Developmen and Validation of remogliflozin etaboante and metformin hcl and its Degradant in its Capsule Dosage Form” J. Pharm. Sci. and Res., 2017; 9(9): 1549-155.
11. Harne UV, Birajdar L, Damle MC, “Development and validation of stability indicating HPLC method for determination ofremogliflozin etaboante” World J. Pharm. Res., 2017; 6(11): 430-441.
12. Harne UV, Birajdar L, Damle MC, “Development and validation of stability indicating HPLC method for determination of metformin hcl” World J. Pharm. Res., 2017; 6(11):430-432.
13. Saxena V, Zaheer Z, Farooqui M, “Stability Indicating RP-HPLC Method for the Determination of remogliflozin etaboante and metformin hcl in Pharmaceutical formulation” Ind. J. of Chem. Tech. Res., 2006; 13: 242-246.
14. Vasanthraju SG, Mishra A, Karthik A, Mausmade PP, Udupa N, “Stability Indicating RPHPLC Method For Determination of metformin hcl in Solid Dosage Form” J. Pharm. Res., 2009; 8(4): 184-186